HR 3561 · 118th Congress 2023–2025, ended

PATIENT Act of 2023

Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 22, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023

This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps.

Specifically, the bill provides statutory authority for the requirement that hospitals publish an annual list of shoppable services they provide, including specified pricing information. Beginning in 2025, a hospital may not use an internet-based price estimator tool to meet the publication requirement for shoppable services.

The bill also modifies the health insurance plan disclosure requirements to include the rates for certain in-network services and prescription drug payment information.

The bill further requires providers of diagnostic laboratory tests under Medicare to publish online certain price information. Medicare Advantage (MA) organizations must report information about payments made to providers in which the MA organization has an ownership interest. Medicare prescription drug plan sponsors must report certain price information for covered drugs.

Additionally, the bill requires health insurance plan issuers (or the PBM providing services on behalf of the plan) to report to the plan sponsor specified information about prescription drugs dispensed under the plan. This includes rebates, fees, alternative discounts, or other remuneration the plan receives from drug manufacturers.

Finally, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid.

Cosponsors 88

Members who signed on, in the order they did. Signatures ran from May 22, 2023 to Sep 29, 2023; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-NJFrank Pallone, Jr.OriginalMay 22, 2023
R-GAEarl L. "Buddy" CarterJun 7, 2023
D-MNAngie CraigJun 21, 2023
D-NHAnn M. KusterJun 21, 2023
R-OHBill JohnsonJun 21, 2023
R-KYBrett GuthrieJun 21, 2023
R-TNDiana HarshbargerJun 21, 2023
R-FLGus M. BilirakisJun 21, 2023
R-CAJay ObernolteJun 21, 2023
R-PAJohn JoyceJun 21, 2023
D-MDJohn P. SarbanesJun 21, 2023
R-FLKat CammackJun 21, 2023
R-INLarry BucshonJun 21, 2023
D-CANanette Diaz BarragánJun 21, 2023
R-FLNeal P. DunnJun 21, 2023
R-NCRichard HudsonJun 21, 2023
R-GARick W. AllenJun 21, 2023
R-OHRobert E. LattaJun 21, 2023
R-OKStephanie I. BiceJun 21, 2023
R-OHTroy BaldersonJun 21, 2023
R-FLVern BuchananJun 21, 2023
R-NJChristopher H. SmithJun 23, 2023
R-LAClay HigginsJun 23, 2023
R-TXDan CrenshawJun 23, 2023
R-AZDebbie LeskoJun 23, 2023
R-KSJake LaTurnerJun 23, 2023
D-ILJanice D. SchakowskyJun 23, 2023
R-SCJeff DuncanJun 23, 2023
R-UTJohn R. CurtisJun 23, 2023
R-IAMariannette Miller-MeeksJun 23, 2023
D-CAScott H. PetersJun 23, 2023
R-ALBarry MooreJun 30, 2023
R-TXBeth Van DuyneJun 30, 2023
R-TXBrian BabinJun 30, 2023
R-ARBruce WestermanJun 30, 2023
R-FLCory MillsJun 30, 2023
D-CADoris O. MatsuiJun 30, 2023
R-NYElise M. StefanikJun 30, 2023
R-MIJack BergmanJun 30, 2023
R-MIJohn JamesJun 30, 2023
R-MIJohn R. MoolenaarJun 30, 2023
R-TXMonica De La CruzJun 30, 2023
R-TXPat FallonJun 30, 2023
D-FLSheila Cherfilus-McCormickJun 30, 2023
D-NVSusie LeeJun 30, 2023
D-COYadira CaraveoJun 30, 2023
D-CAAdam B. SchiffJul 6, 2023
R-INVictoria SpartzJul 6, 2023
D-NCDonald G. DavisJul 11, 2023
R-INJames R. BairdJul 11, 2023
D-NYYvette D. ClarkeJul 11, 2023
R-FLCarlos A. GimenezJul 13, 2023
D-FLDarren SotoJul 13, 2023
D-MIDebbie DingellJul 13, 2023
D-NMGabe VasquezJul 13, 2023
R-AZJuan CiscomaniJul 13, 2023
R-NDKelly ArmstrongJul 13, 2023
D-DELisa Blunt RochesterJul 13, 2023
D-MALori TrahanJul 13, 2023
D-ILRobin L. KellyJul 13, 2023
R-TXRonny JacksonJul 13, 2023
D-COBrittany PettersenJul 18, 2023
D-TXMarc A. VeaseyJul 18, 2023
D-CARaul RuizJul 18, 2023
D-AZRuben GallegoJul 18, 2023
D-MIShri ThanedarJul 18, 2023
D-PASusan WildJul 18, 2023
D-CATed LieuJul 18, 2023
D-CATony CárdenasJul 19, 2023
D-PAChristopher R. DeluzioJul 25, 2023
D-TXLizzie FletcherJul 25, 2023
D-TXSheila Jackson LeeJul 25, 2023
D-ORAndrea SalinasJul 26, 2023
R-NYGeorge SantosJul 26, 2023
D-NJJefferson Van DrewJul 26, 2023
D-CAJosh HarderJul 27, 2023
D-CODiana DeGetteAug 1, 2023
D-WAKim SchrierAug 1, 2023
D-CAMark TakanoAug 1, 2023
D-NJAndy KimAug 11, 2023
R-FLBill PoseyAug 11, 2023
D-AZGreg StantonAug 11, 2023
D-MIRashida TlaibAug 25, 2023
D-NCKathy E. ManningSep 8, 2023
R-KYHarold RogersSep 18, 2023
D-MNBetty McCollumSep 26, 2023
R-GARichard McCormickSep 29, 2023
D-NCWiley NickelSep 29, 2023

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 22, 2023Markup May 24, 2023
HouseWays and Means Committee
Referred May 22, 2023
Health Subcommittee
Referred Dec 17, 2024
HouseEducation and Workforce Committee
Referred May 22, 2023

Actions 5

Everything that happened, newest first.

  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. May 24, 2023Committee Consideration and Mark-up Session Held.
  3. May 24, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
  4. May 22, 2023Introduced in House
  5. May 22, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimate

  1. Jul 11, 2023Estimated Direct Spending and Revenue Effects of H.R. 3561, the PATIENT Act of 2023As Ordered Reported by the House Committee on Energy and Commerce on May 24, 2023

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 3 The single subject of this legislation is: To lower costs for and improve the health of patients.

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 86, May 22, 2023, page H2501.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 118-661CONSOLIDATION AND CORPORATE OWNERSHIP IN HEALTH CARE: TRENDS AND IMPACTS ON ACCESS, QUALITY, AND COSTS177 pagesFinance CommitteeJun 8, 2023

Related bills 12

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 775Increasing Transparency in Generic Drug Applications ActRelated billMar 14, 2023
S 1038Drug Price Transparency in Medicaid Act of 2023Related billMar 29, 2023
HR 1613Drug Price Transparency in Medicaid Act of 2023Related billMar 24, 2023
HR 2665Supporting Safety Net Hospitals ActRelated billApr 18, 2023
HR 2679Pharmacy Benefits Manager Accountability ActRelated billDec 17, 2024

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To promote hospital and insurer price transparency, and for other purposes.
Short Title(s) as Introduced
PATIENT Act of 2023
Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 22, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.